Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > TB500 for Sale > High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - large image1
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - image1
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - image2
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - image3
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - image4
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - image5
High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder buy - image6

High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder

TDS 35 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

885340-08-9

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

10mg/Vial

Price valid (until):

2026-10-10

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  



    1. BT10 10mg – Product Description

      Product Overview

      BT10 10mg is a commercial product supplied according to the applicable product specification, quality requirements, and manufacturer documentation. The product is identified by the commercial designation BT10 and the specified quantity of 10 mg.

      The exact chemical identity, composition, grade, purity, physical and chemical properties, safety characteristics, packaging configuration, regulatory classification, and other technical information should be confirmed using the manufacturer's current official documentation before purchase or use.

      This product description is intended for general product identification and professional business communication. It does not replace the official Product Specification, Certificate of Analysis (COA), Safety Data Sheet (SDS), product label, regulatory documentation, or other technical documents applicable to the actual product.

      Customers should review all relevant documentation and confirm the applicable legal and regulatory requirements before purchasing, importing, exporting, transporting, storing, handling, processing, distributing, or using BT10 10mg.

      Product Information

      Product Name: BT10 10mg
      Product Code: BT10
      Specified Quantity: 10 mg
      Product Form: According to the actual product supplied
      Grade: According to the manufacturer's applicable specification
      Purity: According to the applicable product specification and batch COA
      Packaging: According to the actual packaging configuration
      Chemical Name: To be confirmed according to the actual product
      CAS Number: To be confirmed according to the exact chemical identity
      Molecular Formula: To be confirmed where applicable
      Molecular Weight: To be confirmed where applicable
      Origin: To be confirmed according to the actual supply arrangement
      Manufacturer/Supplier: To be confirmed by the supplier

      All product information published on the marketplace should correspond to the actual product, physical packaging, commercial documentation, and supporting technical records.

      The commercial designation “BT10” should not be considered a substitute for the confirmed chemical identity. Where a chemical name, CAS number, composition, or other identifying information is required, it should be taken from the applicable official documentation.

      Product Characteristics

      BT10 10mg is supplied according to the manufacturer's applicable product specification and quality-control procedures.

      The actual characteristics of the product should be established using current technical documentation. Depending on the actual product, relevant parameters may include appearance, assay, purity, concentration, physical state, moisture content, stability, or other quality specifications.

      Specific numerical values should only be stated when supported by official product documentation or applicable batch records.

      If a particular technical parameter has not been verified, it should not be presented as a guaranteed characteristic of the product.

      Customers requiring detailed technical information should request the applicable Product Specification, COA, SDS, or other supporting documentation before making a purchasing or technical decision.

      Quality Assurance

      Quality assurance for BT10 10mg should be based on the manufacturer's applicable quality-management and quality-control procedures.

      Where available, a Certificate of Analysis may provide batch-specific information concerning product quality and conformity with the applicable specification.

      Customers should confirm that any COA provided corresponds to the actual product, batch number, quantity, and specification being supplied.

      For applications requiring strict quality standards, customers may establish their own incoming inspection, qualification, and acceptance procedures in accordance with their internal quality-management systems and applicable legal requirements.

      General quality-control information should not be interpreted as a guarantee that the product is suitable for a particular downstream application unless such suitability has been specifically demonstrated and documented.

      Technical Documentation

      Customers requiring technical, safety, or compliance information should request the appropriate documentation before proceeding with a transaction.

      Depending on the actual characteristics and regulatory status of BT10 10mg, applicable documents may include:

      • Product Specification
      • Certificate of Analysis (COA)
      • Safety Data Sheet (SDS), where applicable
      • Product label information
      • Packaging specifications
      • Transportation information, where applicable
      • Regulatory or compliance documentation, where applicable
      • Other manufacturer-issued technical documentation

      The availability of specific documentation may depend on the product, production batch, supplier, destination jurisdiction, and applicable legal requirements.

      All documentation should accurately correspond to the product being offered. Documents relating to another product, grade, formulation, or chemical identity should not be substituted.

      Safety Information

      Safety information should be obtained from the current SDS and other official safety documentation applicable to the actual product.

      Personnel involved in receiving, storing, transporting, handling, processing, or disposing of BT10 10mg should review the relevant safety information and follow appropriate workplace procedures.

      Because the exact chemical identity and hazard classification have not been specified in this general product description, this page does not independently assign a hazard classification.

      Users should not infer that the product is non-hazardous, exempt from regulation, or unrestricted solely because of its commercial name, quantity, packaging, or appearance.

      If the actual product is classified as hazardous or subject to special controls, users should follow the applicable SDS, workplace procedures, and legal requirements.

      Storage

      BT10 10mg should be stored according to the manufacturer's current storage recommendations and applicable safety documentation.

      Actual storage conditions should be confirmed from official documentation. Depending on the confirmed characteristics of the product, relevant considerations may include temperature, humidity, light exposure, ventilation, container integrity, and compatibility with other materials.

      The product should remain in suitable and correctly identified packaging during storage.

      Containers should be maintained in appropriate condition and protected from circumstances that could adversely affect product quality, safety, or package integrity.

      Where applicable regulations establish additional storage requirements, those requirements should be followed together with the manufacturer's recommendations.

      Handling

      BT10 10mg should be handled by appropriately trained personnel using procedures suitable for the confirmed properties of the product.

      Before handling, users should review the current SDS and establish appropriate workplace safety procedures.

      Unauthorized repackaging, relabeling, modification, or transfer should be avoided where these activities could affect product identity, quality, safety, traceability, or regulatory compliance.

      Any processing, dilution, formulation, mixing, or other modification should only be performed when supported by appropriate technical information and permitted by applicable requirements.

      Specific operating conditions should not be inferred from the product code or specified quantity.

      Packaging

      The packaging configuration for BT10 10mg should be appropriate to the actual product characteristics and applicable storage and transportation requirements.

      Final packaging details should be confirmed with the supplier before shipment.

      Where special packaging, labeling, marking, or documentation requirements apply, those requirements should be established before dispatch.

      Upon receipt, customers should verify the product name, quantity, packaging integrity, batch information, labeling, and accompanying documentation.

      If packaging is damaged or product identification is inconsistent with the purchasing documentation, the customer should follow the applicable supplier procedures and avoid using the product until the discrepancy has been resolved.

      Transportation

      Transportation requirements should be determined according to the confirmed properties and classification of the actual product and the applicable regulations in the shipping and destination jurisdictions.

      If BT10 10mg is classified as dangerous goods or is otherwise subject to transportation controls, all applicable requirements concerning packaging, labeling, documentation, carriers, and transport arrangements must be followed.

      Transportation classification should not be determined solely from the commercial designation “BT10 10mg.”

      Where required, transportation information should be confirmed through the current SDS, official technical documentation, and applicable regulatory requirements.

      Customers and logistics providers should ensure that transportation arrangements are appropriate for the actual product and destination.

      Regulatory Compliance

      The regulatory status of BT10 10mg should be evaluated according to its confirmed chemical identity, composition, concentration, intended application, country or region of origin, destination market, and applicable laws and regulations.

      Certain chemical products may be subject to requirements concerning hazardous chemicals, chemical registration, storage, transportation, occupational safety, environmental protection, import and export controls, or other regulatory measures.

      Regulatory requirements may differ between jurisdictions and may depend on the actual composition and intended use of the product.

      Therefore, the regulatory status of BT10 10mg should be determined using its actual product identity and applicable legal requirements rather than its commercial designation.

      Customers are responsible for confirming the requirements applicable to their own activities before conducting transactions involving the product.

      Dangerous Chemical and Restricted Product Requirements

      If BT10 10mg is determined to fall within a regulated dangerous-chemical category or another restricted category, the applicable legal and platform requirements must be followed.

      Where a license, permit, registration, qualification, or other authorization is legally required, the relevant requirements should be satisfied before conducting activities for which such authorization is necessary.

      If ECHEMI requests supporting qualification documents for the product, the supplier should submit genuine and applicable documentation through the appropriate platform review process.

      The product should not be presented under an alternative designation, misleading identity, incomplete description, or modified terminology for the purpose of avoiding platform review or regulatory controls.

      Regulatory status should not be concealed, minimized, or misrepresented.

      The online product information should remain consistent with the actual product, packaging, technical documentation, safety documentation, and applicable regulatory records.

      Intended Use

      BT10 10mg should only be used for applications supported by the manufacturer's technical documentation and permitted under applicable laws and regulations.

      Specific application claims should only be included when they are supported by appropriate technical evidence.

      Customers are responsible for determining whether the product is technically suitable for their intended process, facility, equipment, personnel, and regulatory environment.

      This general product description does not grant approval, certification, authorization, or suitability for any particular application.

      Where an intended application is subject to additional regulatory requirements, customers should complete the appropriate assessment and authorization process before use.

      Product Listing Compliance

      Information published on a B2B marketplace should accurately represent the actual product offered by the supplier.

      The product name, chemical identity, CAS number where applicable, specification, quantity, packaging, quality information, safety information, and regulatory statements should be consistent with genuine supporting documentation.

      Material information should not be intentionally altered, concealed, split, abbreviated, or omitted for the purpose of bypassing platform review or regulatory requirements.

      If ECHEMI determines that BT10 10mg requires additional qualification or documentation, the supplier should follow the applicable review process.

      A compliant product listing should prioritize accuracy, transparency, traceability, and consistency between the online listing and the actual product documentation.

      Customer Responsibilities

      Before ordering BT10 10mg, customers should verify:

      1. The exact chemical identity of the product.
      2. The applicable Product Specification.
      3. The quantity and packaging configuration.
      4. The latest available SDS and technical documentation.
      5. Available batch-specific quality information.
      6. The regulatory classification applicable in the destination jurisdiction.
      7. Any applicable import or export requirements.
      8. Any required storage, handling, or transportation authorization.
      9. The suitability of the product for the intended application.
      10. Any additional requirements imposed by local authorities or internal compliance procedures.

      Customers should maintain appropriate purchasing, quality, safety, and compliance documentation where required.

      Supplier Responsibilities

      The supplier should ensure that all information published for BT10 10mg is accurate, current, and supported by genuine product documentation.

      Technical, quality, safety, and regulatory information should remain consistent with the latest applicable documents.

      Where customers request supporting documentation, the supplier should provide the applicable materials where legally and commercially permissible.

      If the product is subject to special qualification requirements, the supplier should ensure that relevant qualifications are valid and applicable to the actual product and business activity.

      Important Notice

      This product description is intended for general commercial and technical communication.

      It does not constitute a guarantee of regulatory approval, transportation eligibility, application suitability, or authorization for any specific use.

      The official Product Specification, SDS, COA, product label, and applicable regulatory documentation should be used as the primary references for technical, safety, and compliance decisions.

      Regulatory requirements may change over time and may differ between jurisdictions. Customers should obtain current information before purchasing, importing, exporting, transporting, storing, handling, processing, or using BT10 10mg.

      If any inconsistency exists between this general product description and official technical, safety, or regulatory documentation, the official documentation should take precedence.

      Pre-Publication Compliance Verification

      Before publishing BT10 10mg on ECHEMI, the supplier should verify:

      Product identity → Exact chemical name → CAS number, where applicable → Composition → Specification → SDS → Hazard classification → Regulatory status → Required qualification → Packaging → Transportation requirements → Destination-market requirements.

      If the product is confirmed to be subject to dangerous-chemical or other restricted-product requirements, the supplier should complete the applicable qualification and documentation process before commercial publication.

      If required qualification documents have not yet been uploaded or verified, the listing should remain subject to ECHEMI's applicable review requirements.

      The product should not be renamed, disguised, or described inaccurately in order to avoid regulatory or platform review.

      The purpose of this product description is to provide clear, accurate, professional, and compliance-oriented product information without making unsupported claims or attempting to bypass applicable controls.

      BT10 10mg should be supplied, transported, stored, handled, and used only in accordance with the applicable product documentation, safety requirements, regulatory requirements, and manufacturer's instructions.


    Items Specifications
    Product Name BT10
    Grade Research Grade
    Package 10mg/Vial
    Appearance White Lyophilized Powder
    Model BT10 10mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    TB 500 is a synthetically made version of TB4 that facilitates healing and recovery by helping build new blood vessels, muscle tissue fibers, blood cells, and facilitating cell migration. It acts on the muscular system and has anabolic properties. TB 500 is used primarily for race animals (horses and dogs).

    Certificates
    • High Quality BT10 Peptide CAS No 885340-08-9 Lab Grade Peptides Powder Certificates 1 TDS

    Basic Info
    Product Name:

    TB500

    Other Name:

    TB500 fragment;L-Glutamine, N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-α-glutamyl-L-threonyl-;Thymosin Beta 4 Peptide Peptides Tb500 2mg/Vials 5mg/Vials;TB500 fragment acetate;TB500 Thymosin Beta 4 (TB4);Ac-LKKTETQ;Thymosin β4 TB500;TB500(Thymosin B4 AceTate) 5MG 10MG

    CAS No.:

    885340-08-9

    Molecular Formula:

    C38H68N10O14

    InChIKeys:

    ADKDNDYYIZUVCZ-HLXZCORBNA-N

    Molecular Weight:

    889.02

    EC Number:

    232-660-2

    Color/Form:

    White to Off-White

    Characteristics
    Density:

    1.281±0.06 g/cm3(Predicted)

    Boiling Point:

    1405.0±65.0 °C(Predicted)

    PKA:

    3.20±0.10(Predicted)

    Research
    Class:

    Actin-sequestering protein / 43-amino-acid peptide

    Status:

    Research compound — Not FDA approved (investigational: RGN-259 for dry eye / neurotrophic keratitis)

    Mechanism:

    A naturally occurring 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) that binds G-actin (sequesters monomeric actin), preventing F-actin polymerization. Promotes cell migration, angiogenesis, wound healing, and anti-inflammatory responses via integrin-linked kinase (ILK) and HIF-1α/VEGF pathways. TB-500 is the synthetic fragment Ac-LKKTETQ (MW ~895) often sold under this CAS.

    Activity note:

    Thymosin Beta-4 is an actin-binding protein, not a receptor agonist. Functional activity is measured by actin sequestration (Kd ~0.7–1 μM) and cell migration assays, not EC₅₀.

    Source:

    Goldstein AL, et al. Vitam Horm. 2003;66:257–296. RegeneRx RGN-259 clinical program.DOI

    Clinical Development:

    NCT02974907; NCT02600429; NCT00376974

    References
    DrugBank:

    DB04951

    PubChem:

    PubChem

    UNII:

    549LM7U24W

    Disclaimer:

    Thymosin Beta-4 (TB-500) is NOT FDA-approved for human therapeutic use. RGN-259 (Tβ4 ophthalmic solution) is an investigational drug not yet approved. TB-500 sold on research-chemical marketplaces is a synthetic fragment and is not an approved medicine. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    35 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Factory price CAS 885340-08-9 L-Glutamine TB500

    1 KG Sep 26, 2023
    United States

    TB500 99% White powder Beta-4 CAS 885340-08-9 powder Custom peptides

    1000  Oct 30, 2023
    United States

    TB 500

    150 MG Apr 8, 2026
    United States

    China Origin TB500 2mg/5mg/10mg Lyophilized Powder for the Wound Repair Research

    1 G Mar 26, 2026
    United States

    TB500

    100 MG Feb 27, 2026
    Germany

    TB 500

    1 KG Feb 8, 2026
    Portugal

    Tb 500

    10 MT Aug 7, 2024
    France

    TB500

    1 KG Mar 27, 2024
    United States

    TB500

    1 G Jan 27, 2024
    Brazil

    TB-500

    1 G Jun 18, 2026
    Canada

    TB 500

    1 KG May 8, 2026
    United States

    TB 500

    20 G Feb 23, 2026
    Brazil

    alejandro

    300 PCS Feb 19, 2026
    United States

    TB500 10mg

    1 MT Oct 20, 2025
    United States

    Tesomorelin

    1 KG Aug 8, 2025
    Italy

    TB500

    1000 MG Dec 30, 2024
    Netherlands

    tb500

    Dec 16, 2024
    New Zealand

    TB500

    100 MG Jun 24, 2024
    Germany

    High Purity 99% Tb-500 5mg TB 500 Peptide TB500

    1 MT Oct 19, 2023
    United States

    High Purity 99% Tb-500 5mg TB 500 Peptide TB500

    10 MT Oct 12, 2023
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.